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1. Introduction 
in previous studies we have been unable to detect 
more than a slight effect of interferon treatment of 
cells in the absence of infection upon the ability of 
cell-free systems isolated from them to translate a 
viral RNA [ 11. None the less it would appear that in 
vaccinia virus-infected L cells pretreated with inter- 
feron it is virus protein synthesis which is inhibited: 
virus messenger RNA (mRNA) is synthesized but is 
not translated [2, Metz and Esteban, in preparation]. 
Here, therefore, we report the results of an investi- 
gation of the effect of interferon pretreatment on 
the translation of a viral RNA in cell-free systems 
from vaccinia vims-infected ceils. Extracts from 
mouse L cells translated encephalomyocarditis (EMC) 
virus RNA and mouse globin mRNA to yield EMC- 
specific polypeptides and mouse globin. Under the 
conditions employed, infection or pretreatment of 
the cells with interferon alone had little effect on 
the translation of EMC RNA in these systems. With 
extracts from cells subjected to both interferon treat- 
ment and infection, however, the translation of EMC 
RNA was strikingly inhibited. The bulk of the inhi- 
bitory effect appeared to be associated with the ribo- 
some fraction. Inhibition was not seen if the cell- 
free systems were prepared in the conventional 
manner by preincubation of the extracts at 37”. 
Thus, both interferon treatment and infection appear 
to be required before a clear-cut effect on translation 
can be seen in the cell-free system. 
2. Materials and methods 
The growth of EMC virus, the extraction of EMC 
RNA [3] and of mouse globin mRNA [4], the label- 
ling of the polypeptide products in the cell-free sys- 
tem and their analysis by electrophoresis on polyacryl 
amide gels in the presence of sodium dodecyl sulphate 
(SDS) have already been described [5]. Mouse inter- 
feron prepared by the method of Paucker [6] con- 
tained > 10’ units/mg of protein expressed in terms 
of the N.I.H. Mouse Serum Interferon Reference 
Reagent. Interferon treatment (1.5 X IO6 L cells/ml) 
was routinely with 50 units/ml for 4 hr at 37”. The 
cells were diluted to 7.5 X IO5 /ml and incubation con 
tinued for 17 hr. They were then infected with puri- 
fied vaccinia virus (500 particles/cell) and harvested 
at i hr post infection [2]. The preparation of the 
cytoplasmic extracts will be described elsewhere 
(Friedman et al., in preparation). 
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Table 1 
Amino acid incorporation in response to EMC RNA or mouse globin mRNA in L cell extracts. 
[ 14Cj amino acid incorporation 
(counts per min per assay) 
mRNAk9 0 0.5 1 2 3 4 5 
Globin 1,000 - _ 5,700 6,400 6,200 5,900 
EMC RNA 1,300 16,000 18,300 29,800 36,300 21,400 
The cell-free systems from L cells employed post-mitochondrial supernatant fractions which had been preincubated for 45 mm 
at 37” and passed through Sephadex G-25. Amino acid incorporation in the presence of added RNA was over 120 min at 30”. 
Fig. 1. Analysis of the polypeptide products from the cell- 
free systems by electrophoresis on SDS-poiyacrylamide gels. 
A) with EMC RNA (5% gel); B) no added RNA (7.5% gel); 
C) with globin mRNA (7.5% gel). Autoradiographs of the 
sliced dried gels are shown. 
3. Results and discussion 
3.1. Translation of EMC and globin messenger RNA’s 
in the cell-free system - ~~r~~teris~t~on of the 
polypeptide products 
The optimal conditions for the st~ulation of 
amino acid incorporation by EMC RNA or by mouse 
‘73 
globin mRNA differed slightly. For EMC RNA the 
K’ and Mg’+ concentrations were, respectively, I 10 
mM and 4.5 mM; for globin mRNA, 50 mM and 
3.5 mM. In both cases, incorporation in response 
to the RNA was better at 30” than 37”. Table 1 shows 
the effect of various concentrations of EMC RNA 
and of mouse globin mRNA on the incorporation of 
“C-iabelled amino acids in the presence of preincu- 
bated extracts of L cells. Incorporation was linear 
over at least a 2 hr period. 
The products formed in such incubation mixtures 
have been analyzed by electrophoresis on SDS-poly- 
acrylamide gels (fig. 1). In the case of mouse globin 
mRNA the single polypeptide product (fig. 1) mi- 
grated with mouse globin. After 4 hr of incubation in 
the presence of EMC RNA a polypeptide with a mo- 
lecular weight of about 140,000 was the major prod- 
uct. A similar large polypeptide has been previously 
identified as being characteristic of EMC RNA direct- 
ed protein synthesis in Krebs ascites cell extracts [5]. 
Moreover, conlparison of tryptic peptides from the 
EMC RNA directed product with those from authen- 
tic EMC polypeptides, as described previously [ 7) , 
established their identity. 
3.2. Interjkron mediated inhibition of virus protein 
synthesis in vaccinia virus-infected cells 
Interferon treatment has no marked effect on RNA 
or protein synthesis in normal cells [ 8, 91 whereas 
in virus-infected cells viral protein synthesis at least 
is markedly inhibited [2]. Our studies with interferon 
treated vaccinia virus-infected L cells have confirmed 
these findings. On normal vaccinia virus infection of 
cells in the absence of interferon pretreatment, host 
protein synthesis is inhibited and vaccinia virus speci- 
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fit peptides can be clearly detected 30 min post in- 
fection. By 1 hr after infection protein synthesis is 
predominantly vaccinia virus directed (fig. 2). In 
interferon-treated cells, however, all protein synthe- 
sis is markedly inhibited (fig. 2). It is not yet clear 
whether this overall inhibition reflects the sum of 
the inhibition of host protein synthesis by a com- 
ponent of the vaccinia virion [lo] and of viral pro- 
tein synthesis by interferon, or a blanket i~ibition 
of all protein synthesis in the interferon-treated cell 
which is triggered by virus infection. 
3.3. Interferon mediated inhibition of virus protein 
synthesis in cell-free systems from vaccinia 
vies-infested cells 
Since the antiviral state was clearly established in 
these interferon-treated vaccinia virus-infected cells, 
extracts from them were assayed in the cell-free sys- 
tem and a marked inhibition of the translation of 
EMC RNA was observed (table 2). This was true pro- 
vided that the extracts were not subjected to a pre- 
incubation step to reduce endogenous incorporation. 
Such preincubation reversed the inhibition and re- 
stored the system to full activity (table 2). On frac- 
tionation of the extracts the inhibition appeared to 
be predominantly (70 to 8%) associated with the 
ribosome fraction although some effect was seen 
with the cell sap (‘20 to 3070) (table 3). The polypep- 
tide products synthesized in response to the EMC 
RNA in the three extracts in table 2 which showed 
a normal response to the RNA behaved identically 
on electrophoresis on SDS-polya~~l~ide gels to 
those synthesized in preincubated extracts from un- 
infected cells (fig. 1). Those synthesized in the sys- 
tem showing an inhibition of translation, i.e. the non- 
preincubated system from interferon-treated vaccinia- 
infected cells, were heterogeneous and of lower mo- 
lecular weight. It would seem, therefore, that in 
these cell-free systems from interferon-treated infectec 
Fig. 2. Effect of interferon treatment on protein synthesis in 
vaccinia virus-infected L cells. The polypeptides synthesized 
in: A) uninfected cells, B) vaccinia ~rus-infested, and 
C) interferon-treated vaccinia virus-infected cells were anal- 
yzed by electrophoresis on SDS-polyacrylamide gels (Esteban 
and Metz, in preparation). Incorporation of [ 35S] methionine 
was over a 20 min period 1 hr post infection. Autoradio- 
graphs of the sliced dried gels are shown. 
Volume 24. number 3 I:EBS LETTERS August 1972 
Table 2 
Translation of EMC RNA by extracts from vaccinia virus-infected cells: effect of interferon pretreatment of cells and of preincu- 
bation of the cell-free system. 
Cells 
Interferon 
(50 units/ml) 
Treatment of 
Vaccinia 
virus 
infection 
Lxtract 
Preincubation 
(37”, 40 min) 
[“CT] amino acid incorporation in response to 
EMC RNA with time 
(counts per min per 50 PI)* 
10 min 40 min 90 min I50 min 
+ + 100 680 3050 5070 
+ + + 160 630 3260 4740 
_ + 500 2100 3420 4310 
+ + 200 440 670 870 
Post mitocl~ondrial su~ernatant fractions were used without passage through Sephadex. StiRlulation of incorporation was with 
2 pg of EMC RNA. Incorporation in the absence of EMC RNA did not exceed a maximum of 200 counts per min. 
* 50 ~1 samples were taken from each of four 0.5 ml incubation mixtures. 
Tabfe 3 
Translation of EMC RNA in cell-free systems using ribosome 
and cell sap fractions from vaccinia virus-infected and 
interferon-treated vaccinia virus-infected cells. 
[ 14C] amino acid incorporation in 
response to EMC RNA 
(counts per min per assay) 
Ribosomes* 
from 
With cell sap* from 
Infected cells Interferon-treated 
infected cells 
infected cells 11,600 8,800 
interferon-treated 
infected cells 2,800 2,200 
* The pellets (ribosome fraction) from centrifugation of the 
postmitochondrial supernatant fractions at 140,000 g for 
1 hr were resuspended in 90 mM KG, 3.5 mM Mg acetate, 
30 mM Tris HCi pH 7.5 and 7 mM ~-mercaptoetllano1. 
The supernatants were the cell sap fractions. The incuba- 
tions were equal amounts of the different ribosome and 
cell sap fractions for 120 min at 30” in the presence of
2 pg of EMC RNA. The values for amino acid incorpora- 
tion in the absence of EMC RNA were 2100 and 2500 
with the ribosomes from infected cells and 500 and 700 
with those from interferon-treated infected cells, respect- 
ively, for the cell sap fractions from interferon-treated 
infected and infected cells. 
cells, EMC virus protein synthesis is inhibited, the 
inhibition apparently affecting both the initiation 
and the translocation steps in the translation of 
EMC RNA. It is not yet clear whether the transla- 
tion of globin mRNA is similarly affected for there 
is no significant stimulation of incorporation in re- 
sponse to this RNA in any of the nonpreincubated 
cell-free systems. While preliminary analysis of the 
product synthesized in the presence of this RNA 
would suggest hat it is translated in all of these sys- 
tems, a definitive answer will have to await the re- 
sults of a more detailed study. The translation of 
polyuridylic acid was not inhibited in the system 
showing an inhibition in the translation of EMC 
RNA. 
Control experiments showed that the difference 
in incorporation with and without interferon treat- 
ment (tables 2 and 3) cannot be explained on the 
basis of differences in pool sizes, nor were there 
gross differences in the levels of RNAase in the sys- 
tems (L.A. Ball, unpublished results). The reduced 
response could not be augmented by the addition 
of excess EMC RNA. That the inhibitory effect on 
the translation of the EMC RNA was indeed inter- 
feron mediated was indicated by the fact that it 
was obtained with highly-purified interferon prep- 
arations from two independent laboratories (the 
second preparation was generously provided by 
Drs. E. Knight and R.Z. Lockart). The extent of the 
inhibition varied with the interferon concentration. 
A significant inhibition (65%) was observed on ex- 
posure of the cells to as little as 5 units/ml of inter- 
feron prior to infection. Inactivation of the antiviral 
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activity of the interferon preparation by heat or 
trypsin treatment abolished the effect observed in 
the cell-free system. It was not seen with cell-free 
systems from Krebs cells which are relatively in- 
sensitive to interferon, nor was it seen on treatment 
of L cells with chick interferon. Finally, the effect 
was not unique to the vaccinia-infected L cell sys- 
tem. Cell-free systems from interferon-treated L 
cells infected with EMC rather than vaccinia virus 
showed a similar reduction in their apparent ability 
to translate a viral RNA. 
The inhibitory effect of interferon pretreatment 
upon the translation of a viral RNA observed here 
was dependent upon virus infection of the interferon- 
treated cell. In the absence of infection interferon- 
treatment resulted in only a slight inhibition of 
translocation in these L cell systems (Friedman et 
al., in preparation). A small effect of interferon pre- 
treatment alone, without infection, has been re- 
ported previously from this laboratory for a chick 
cell-free system [ 11. It may well be, therefore, that 
the antiviral state does not fully develop in the 
interferon-treated cell until after infection. Certainly 
the inhibition of translation of EMC RNA observed 
in these interferon-treated infected cell systems is 
quantitatively sufficient to account for the antiviral 
activity of interferon. The basis for this inhibition 
and its relation to the primary antiviral effect of 
interferon will, however, have to await the results 
of further study. 
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